AXA SA Q1 2026: €38 bn revenue (+3 %) with strong P&C (+2 %) and Life & Health (+7 %) growth, Solvency II 211 %, EPS on track to hit upper 6–8 % range.
AXA SA’s share price barely dipped 0.6 % in a year, yet analysts predict a 24 % upside to €48‑50 by year‑end, thanks to solid insurance earnings and global diversification.
AXA SA’s modest 1.15% yearly return underscores a steady, low‑risk investment, while a renewed AI partnership aims to boost future earnings across 15 global markets.
AXA’s Hong Kong re‑registration consolidates its Greater Bay operations, streamlines compliance, and positions the insurer for stronger cross‑border growth and investor confidence.
AXA SA shares have experienced a 12.33% increase in value over the past 12 months, with a current market capitalization of approximately €87 billion and a price-to-earnings ratio of 15.72.
AXA SA reports mixed financial performance in H1 2025, impacted by forex challenges, but remains optimistic with strategic acquisitions and a strong market position.